batu.bku's blog

Uzbekistan jails AIDS advocate over work for GF and UN

(Posted originally on 26.02.10) An AIDS activist in Uzbekistan has been sentenced to seven years in prison for writing a brochure that authorities said would promote antisocial behaviour, activists said Thursday. Maxim Popov was convicted last September, his colleagues told AFP, but his case only came to light this week after US-based watchdog Human Rights Watch asked local activists to investigate his situation. "Maxim Popov was convicted for writing a brochure which was funded by the Global Fund to Fight AIDS and UNICEF as an effort by international donor organisations to raise awareness about the disease in the country," said an AIDS activist who worked with Popov.

Living with TB: the prehistory of HIV/AIDS from The Lancet

After reading a quote from Dr. Mario Raviglione, Director of WHO Stop TB, "without immediate, massive scale-up, the growing Drug Resistant TB pandemic puts decades of progress in confronting tuberculosis at risk, sending us back to the pre-antibiotic era", I found in The Lancet this interesting article.
---- In 1981, HIV/AIDS arrived in people's lives, at doctors' clinics, and on policy makers' desks. It didn't take long before historical parallels were drawn. AIDS was plague returned, claimed some. Others countered with different historical lessons: people infected with HIV were being treated like lepers. Slightly more on the mark was the precedent sought in historical management of sexually transmitted diseases. Assessed equally as misguided or offering useful templates that could be tweaked, analysing the early “venereal disease” campaigns certainly repaid the policy and historical effort. But one disease that was rarely historically paralleled with HIV/AIDS was tuberculosis. Currently, of course, HIV/AIDS and tuberculosis are alarmingly connected: co-infection fuels the global epidemic of tuberculosis, disproportionately in sub-Saharan Africa. But when reflecting on the history of tuberculosis I've become interested in the similarities between old therapies for tuberculosis and more recent attitudes about managing HIV. The tuberculosis treatment at issue predates the antibiotic innovations of the late 1940s and the artificial pneumothorax fad of the 1930s. It is the “open-air” treatment in the sanatorium, which became popular worldwide from the 1890s. There, consumptives were caught up in some of the earliest conduct-based, risk-minimisation programmes. Patients were not cured of tuberculosis in the sanatorium, nor were they there to die. Rather, the disease would be contained in their bodies, and they would be taught how to live safely in the general community, while never forgetting that they were permanently infective. In short, they were turned into “people living with tuberculosis”.

New Lancet Editorial on Big Pharma in the WHO

[Last week it was known that confidential documents from the WHO Intergovernmental Working Group on Public Health, Innovation and Intellectual Property (IGWG) had leaked to the IFPMA. IFPMA published their comments to the documents, expressing how pleased they were, on their website. Below is an editorial in this week's Lancet and a piece from Ip-watch which found the documents in Wikileaks. Copied as fair use].
http://download.thelancet.com/flatcontentassets/pdfs/S0140673609621231.pdf

Drug development for neglected diseases: pharma's influence

The pharmaceutical industry's latest attempt to sabotage the work of the WHO Intergovernmental Working Group on Public Health, Innovation and Intellectual Property - commonly referred to as IGWG reached a new low last week when the non-governmental organisation, Intellectual Property Watch, noticed two privileged IGWG draft documents and an analysis of the drafts by the International Federation of Pharmaceutical Manufacturers and Associations (IFPMA) on Wikileaks, a website that anonymously publishes sensitive information. This unfortunate situation is a double blow to the member states, public health advocates, and to non-governmental organisations that have strived to make research and development for neglected diseases a feasible reality. Not only has the IFPMA blatantly served its own interests...

Syndicate content